documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

473 rows where agency_id = "FDA", document_type = "Notice" and posted_year = 2005 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 1

  • 2005 · 473 ✖

document_type 1

  • Notice · 473 ✖

agency_id 1

  • FDA · 473 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2003-N-0163-0001 FDA Food Labeling: Ingredient Labeling of Dietary Supplements That Contain Botanicals FDA-2003-N-0163 FDA Notice NWL-Notice of Withdrawl 2005-12-29T05:00:00Z 2005 12 2005-12-27T05:00:00Z   2008-04-12T00:59:12Z   0 0 09000064804886b0
FDA-2005-P-0123-0001 FDA Determine that Decadron (dexamethasone USP) 1.5 mg tablet strength was not removed from the market for safety and efficacy reasons FDA-2005-P-0123 Determination That DECADRON (Dexam@thasone) Tablets, 1.5 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness Notice N-Notice 2005-12-29T05:00:00Z 2005 12 2005-12-27T05:00:00Z   2024-12-13T19:52:31Z   0 0 090000648043fc0c
FDA-2005-N-0467-0001 FDA Animal Drug User Fee Act; Public Meeting FDA-2005-N-0467 Animal Drug User Fee Act; Public Meeting Notice Meeting 2005-12-29T05:00:00Z 2005 12 2005-12-27T05:00:00Z 2006-03-27T04:59:59Z 2025-10-17T19:51:43Z E5-7876 0 0 0900006480450dda
FDA-2005-N-0044-0002 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Reporting: Manufacturer Reporting, Importer Reporting, User Facility Reporting, and Distributor Reporting. FDA-2005-N-0044 Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Reporting: Manufacturer Reporting, Importer Reporting, User Facility Reporting, and Distributor Reporting Notice 60 Day Proposed Information Collection 2005-12-29T05:00:00Z 2005 12 2005-12-23T05:00:00Z 2006-02-03T04:59:59Z 2025-10-17T19:03:49Z E5-7726 0 0 090000648043eafe
FDA-2004-P-0336-0004 FDA Health Claim Petition for Soluble Fiber from Barley FDA-2004-P-0336 FDA Notice NIR-Notice of Interim Rule 2005-12-29T05:00:00Z 2005 12 2005-12-23T05:00:00Z 2006-03-09T04:59:59Z 2008-04-12T00:49:18Z   0 0 09000064804732ca
FDA-2005-D-0084-0004 FDA Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Document for Maximum Recommended Level for Lead in Candy Likely To Be Consumed Frequently By Small Children, FDA-2005-D-0084 FDA Notice NAD-Notice of Availability of Data 2005-12-27T05:00:00Z 2005 12 2005-12-22T05:00:00Z 2006-03-14T04:59:59Z 2008-04-11T23:46:31Z   0 0 090000648043f444
FDA-2005-D-0084-0001 FDA Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Document for Maximum Recommended Level for Lead in Candy Likely To Be Consumed Frequently By Small Children, FDA-2005-D-0084 FDA Notice NAD-Notice of Availability of Data 2005-12-27T05:00:00Z 2005 12 2005-12-22T05:00:00Z 2006-03-14T04:59:59Z 2008-04-11T23:46:31Z   0 0 090000648043f435
FDA-2005-D-0227-0001 FDA Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Guidance (Edition 2) FDA-2005-D-0227 Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Availability (Edition 2) Notice NAD-Notice of Availability of Data 2005-12-27T05:00:00Z 2005 12 2005-12-23T05:00:00Z 2006-12-28T04:59:59Z 2008-07-09T14:52:06Z   0 0 090000648044205e
FDA-2005-N-0469-0001 FDA Agency Information Collection Activities; Reclassification Petitions for Medical Devices FDA-2005-N-0469 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reclassification Petitions for Medical Devices Notice 30 Day Proposed Information Collection 2005-12-27T05:00:00Z 2005 12 2005-12-23T05:00:00Z   2025-10-08T01:51:00Z E5-7804 0 0 0900006480450e3e
FDA-2005-N-0096-0001 FDA Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs FDA-2005-N-0096 Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications Notice Withdrawal 2005-12-23T05:00:00Z 2005 12 2005-12-15T05:00:00Z   2025-06-19T01:11:14Z   0 0 090000648043f7c3
FDA-2003-N-0154-0004 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Research Study Complaint Form FDA-2003-N-0154 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Research Study Complaint Form Notice 30 Day Proposed Information Collection 2005-12-23T05:00:00Z 2005 12 2005-12-16T05:00:00Z 2006-01-18T04:59:59Z 2025-03-12T13:12:59Z 05-24102 0 0 090000648048760b
FDA-2004-P-0223-0005 FDA Request the Commissioner of Food & Drugs to Arrange Public Hearings to Cover Relevant Issues Surrounding the Proposal for OTC Sales, Distribution & Use of Hand-Held Doppler Fetoscopes-CLOSED FDA-2004-P-0223 FDA - Notice of Meeting Notice NM-Notice of Meeting 2005-12-22T05:00:00Z 2005 12 2005-12-21T05:00:00Z 2006-03-11T04:59:59Z 2009-04-21T19:53:09Z   0 0 0900006480471211
FDA-2005-D-0335-0008 FDA Draft Voluntary Hazard Analysis and Critical Control Point (HACCP) Manuals for Operators and Regulators of Retail and Food Service Establishments FDA-2005-D-0335 FDA Notice N-Notice 2005-12-22T05:00:00Z 2005 12 2005-12-21T05:00:00Z 2006-01-24T04:59:59Z 2008-04-11T23:47:17Z   0 0 0900006480448cf9
FDA-2005-N-0240-0002 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; FDA Public Health Notification (formerly known as Safety Alert/Public Health Advisory) Readership Survey FDA-2005-N-0240 Agency Information Collection Activities; Proposed Collection; Comment Request; FDA Public Health Notification (formerly known as Safety Alert/Public Health Advisory) Readership Survey Notice 60 Day Proposed Information Collection 2005-12-22T05:00:00Z 2005 12 2005-12-21T05:00:00Z 2006-02-22T04:59:59Z 2025-10-17T19:36:13Z E5-7642 0 0 09000064804440ae
FDA-2005-N-0291-0001 FDA Regulatory Process for Pediatric Mechanical Circulatory Support Devices (Ventricular Assist Devices) FDA-2005-N-0291 Regulatory Process for Pediatric Mechanical Circulatory Support Devices (Ventricular Assist Devices) Notice Meeting 2005-12-21T05:00:00Z 2005 12 2005-12-19T05:00:00Z   2025-10-17T19:21:08Z 05-24271 0 0 0900006480445d51
FDA-1980-N-0049-0163 FDA Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review Notice Notice of Final Rule 2005-12-21T05:00:00Z 2005 12 2005-12-15T05:00:00Z   2020-09-25T13:40:57Z 05-24224 0 0 09000064805ba0aa
FDA-1980-N-0049-0162 FDA Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order Notice General Notice 2005-12-21T05:00:00Z 2005 12 2005-12-15T05:00:00Z   2020-09-25T13:43:01Z 05-24223 0 0 09000064805ba0a9
FDA-2005-D-0287-0001 FDA Guidance for Industry and Food and Drug Administration: Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006 FDA-2005-D-0287 FDA Notice NAD-Notice of Availability of Data 2005-12-15T05:00:00Z 2005 12 2005-12-13T05:00:00Z   2008-04-11T23:47:13Z   0 0 09000064804458bf
FDA-2004-N-0052-0005 FDA Agency Information Collection Activities: Proposed Collection; Comment Request; Recall Regulations FDA-2004-N-0052 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Food and Drug Administration Recall Regulations (Guidelines) Notice Notice of Approval 2005-12-15T05:00:00Z 2005 12     2025-09-26T22:19:26Z 05-24042 0 0 090000648046e8d8
FDA-2005-N-0470-0002 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Reprocessed Single-Use Device Labeling FDA-2005-N-0470 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reprocessed Single-Use Device Labeling Notice 30 Day Proposed Information Collection 2005-12-15T05:00:00Z 2005 12     2025-10-08T19:51:34Z 05-24041 0 0 0900006480450e57
FDA-2005-N-0230-0004 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs: Study 1 FDA-2005-N-0230 Agency Information Collection Activities; Proposed Collection; Comment Request; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs: Study 1 Notice 30 Day Proposed Information Collection 2005-12-15T05:00:00Z 2005 12     2025-09-16T20:45:50Z 05-24040 0 0 090000648044216d
FDA-2005-N-0332-0001 FDA Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products Containing Coal Tar and Menthol for Over-the-Counter Human Use; Proposed Amendment to the Monograph FDA-2005-N-0332 FDA Notice NPR-Notice of Proposed Rule-Making 2005-12-13T05:00:00Z 2005 12 2005-12-08T05:00:00Z 2006-03-10T04:59:59Z 2008-04-11T23:54:09Z   0 0 0900006480448990
FDA-2005-N-0093-0001 FDA International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Butorphanol; Delta-9-tetrahydrocannabinol (Dronabinol); Gamma-Hydroxybutyric Acid; Ketamine; Khat; Tramadol; Zopiclone; Buprenorphine; Oripavine FDA-2005-N-0093 FDA Notice N-Notice 2005-12-13T05:00:00Z 2005 12 2005-12-12T05:00:00Z 2006-01-13T04:59:59Z 2008-04-11T23:49:48Z   0 0 090000648043f569
FDA-2005-C-0359-0001 FDA Color Additive Petition to Expand the Use of Sodium Copper Chlorophyllin to Include Foods Generally (with the Exception of Meat, Poultry, Fish, and Standardized Foods) and to Include Fescue Grass as a Permitted Source (CAP 6C0281) FDA-2005-C-0359 Food Ingredient Solutions, LLC; Filing of Color Additive Petition Notice Notice of Filing 2005-12-13T05:00:00Z 2005 12     2025-12-04T17:53:51Z 05-23812 0 0 090000648044a7fa
FDA-2005-D-0399-0001 FDA Guidance for Industry and Food and Drug Administration; Nucleic Acid Based In Vitro Diagnostic Devices for Detection of Microbial Pathogens FDA-2005-D-0399 FDA Notice NAD-Notice of Availability of Data 2005-12-08T05:00:00Z 2005 12 2005-12-07T05:00:00Z 2006-03-09T04:59:59Z 2008-04-11T23:47:32Z   0 0 090000648044cfee
FDA-2005-N-0297-0001 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of a Claim for Generally Recognized as Safe Exemption Based on a Generally Recognized as Safe Determination FDA-2005-N-0297 Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of a Claim for Generally Recognized as Safe Exemption Based on a Generally Recognized as Safe Determination Notice 60 Day Proposed Information Collection 2005-12-08T05:00:00Z 2005 12 2005-12-07T05:00:00Z 2006-02-07T04:59:59Z 2025-10-17T09:00:19Z 05-23747 0 0 0900006480446d95
FDA-2005-N-0228-0005 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; State Enforcement Notifications FDA-2005-N-0228 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; State Enforcement Notifications Notice Notice of Approval 2005-12-08T05:00:00Z 2005 12 2005-12-07T05:00:00Z   2025-10-04T01:37:49Z 05-23744 0 0 09000064804420cc
FDA-2004-N-0054-0008 FDA Agency Information Collection Activities; Proposed Collection; MedWatch: The FDA Medical Products Reporting Program; Comment Request FDA-2004-N-0054 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; MedWatch: Food and Drug Administration Medical Products Reporting Program Notice Notice of Approval 2005-12-08T00:00:00Z 2005 12     2025-05-12T22:33:18Z 70 FR 72843 0 0 090000648046e913
FDA-2005-N-0232-0001 FDA Revocation of Status of Specific Products; Group A Streptococcus FDA-2005-N-0232 Revocation of Status of Specific Products; Group A Streptococcus; Companion Document to Direct Final Rule Notice General Notice 2005-12-07T05:00:00Z 2005 12 2005-12-02T05:00:00Z 2006-02-16T04:59:59Z 2025-10-08T19:09:26Z 05-23545 0 0 09000064804421bb
FDA-2005-N-0232-0008 FDA Revocation of Status of Specific Products; Group A Streptococcus FDA-2005-N-0232 Revocation of Status of Specific Products; Group A Streptococcus Notice Notice of Final Rule 2005-12-07T05:00:00Z 2005 12 2005-12-02T05:00:00Z 2006-02-16T04:59:59Z 2025-10-08T19:14:21Z 05-23546 0 0 090000648044224a
FDA-2005-N-0454-0001 FDA Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Acne Ingredient FDA-2005-N-0454 FDA Notice NRD-Notice of Requesting Data, Info, & Views 2005-12-05T05:00:00Z 2005 12 2005-12-05T05:00:00Z 2006-03-07T04:59:59Z 2009-12-30T22:03:14Z   0 0 09000064804507fc
FDA-2005-N-0021-0001 FDA Over-the-Counter Drug Products; Safety & Efficacy Review; Additional Dandruff Control Ingredient FDA-2005-N-0021 Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Dandruff Control Ingredient Notice NRD-Notice of Requesting Data, Info, & Views 2005-12-05T05:00:00Z 2005 12 2005-12-05T05:00:00Z 2006-03-07T04:59:59Z 2020-10-29T12:03:48Z   0 0 090000648043e759
FDA-2004-G-0002-0004 FDA Draft Guidance for Records Access Authority Provided in Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 FDA-2004-G-0002 Guidance for Industry and Food and Drug Administration Staff, Guidance for Records Access Authority Provided In Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Availability Notice Notice of Data Availability 2005-12-02T05:00:00Z 2005 12 2005-11-30T05:00:00Z   2025-11-13T20:43:47Z 05-23504 0 0 090000648046a75b
FDA-2005-N-0041-0002 FDA Medical Device Recall Authority 21 CFR Part 810 FDA-2005-N-0041 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Recall Authority Notice 30 Day Proposed Information Collection 2005-12-02T05:00:00Z 2005 12     2025-10-07T20:49:34Z 05-23519 0 0 090000648043eae1
FDA-2005-D-0208-0001 FDA Guidance for Industry on Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency FDA-2005-D-0208 Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency; Availability Notice NAD-Notice of Availability of Data 2005-12-02T05:00:00Z 2005 12 2005-11-30T05:00:00Z 2006-03-02T04:59:59Z 2008-07-18T05:09:10Z   0 0 0900006480441234
FDA-2005-N-0453-0001 FDA Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients FDA-2005-N-0453 Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients Notice NRD-Notice of Requesting Data, Info, & Views 2005-12-02T05:00:00Z 2005 12 2005-12-05T05:00:00Z 2006-03-07T04:59:59Z 2009-12-30T19:54:55Z   0 0 09000064804507c9
FDA-2004-P-0008-0002 FDA Nutrient Content Claim: Expand Lean Definition FDA-2004-P-0008 FDA Notice NPR-Notice of Proposed Rule-Making 2005-12-01T05:00:00Z 2005 12 2005-11-25T05:00:00Z 2006-02-03T04:59:59Z 2008-04-12T00:46:48Z   0 0 090000648046a7f7
FDA-2005-N-0169-0001 FDA Use of Ozone-Depleting Substance: Essential-Use Determination of Over the Counter Epinephrine Metered-Dose Inhalers FDA-2005-N-0169 FDA Notice NM-Notice of Meeting 2005-12-01T05:00:00Z 2005 12 2005-11-28T05:00:00Z 2006-01-25T04:59:59Z 2008-04-11T23:50:59Z   0 0 0900006480440bc0
FDA-2005-N-0304-0001 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Focus Groups as Used by the Food and Drug Administration FDA-2005-N-0304 Agency Information Collection Activities; Proposed Collection; Comment Request; Focus Groups as Used by the Food and Drug Administration Notice 60 Day Proposed Information Collection 2005-12-01T05:00:00Z 2005 12 2005-11-25T05:00:00Z 2006-01-25T04:59:59Z 2025-10-16T22:19:30Z 05-23248 0 0 090000648044723a
FDA-2005-P-0259-0003 FDA Legal, Scientific and Public Health Issues on Dietary Supplements that Contain the Drug Pyridoxamine are considered adulterated - CLOSED FDA-2005-P-0259 Request for Comment on the Status of Pyridoxamine Notice Notice of Action Taken 2005-11-22T05:00:00Z 2005 11 2005-11-18T05:00:00Z 2005-12-20T04:59:59Z 2025-03-29T18:56:22Z   0 0 09000064804444e1
FDA-2005-N-0030-0006 FDA Regulations for In Vivo Radiopharmaceuticals Used For Diagnosis and Monitoring FDA-2005-N-0030 Agency Information Collection Activities: Announcement of Office of Management and Budget Approval; Regulations For In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring Notice Notice of Approval 2005-11-22T05:00:00Z 2005 11 2005-11-22T05:00:00Z   2025-10-24T00:40:54Z 05-23039 0 0 090000648043e880
FDA-2005-N-0168-0004 FDA Agency Emergency Processing Under OMB Review; Guidance for Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006 FDA-2005-N-0168 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Requesting an Extension to Use Existing Label Stock After the Trans Fat Labeling Effective Date of January 1, 2006 Notice Notice of Approval 2005-11-22T05:00:00Z 2005 11 2005-11-21T05:00:00Z   2025-10-08T00:01:52Z 05-23040 0 0 0900006480440baf
FDA-2005-D-0226-0004 FDA Guidance for Industry: Questions and Answers Regarding the Final Rule on Establishment and Maintenance of Records FDA-2005-D-0226 FDA Notice NAD-Notice of Availability of Data 2005-11-22T05:00:00Z 2005 11 2005-11-21T05:00:00Z   2008-04-11T23:47:01Z   0 0 0900006480441ff3
FDA-2005-N-0168-0005 FDA Agency Emergency Processing Under OMB Review; Guidance for Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006 FDA-2005-N-0168 Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Requesting an Extension to Use Existing Label Stock After the Trans Fat Labeling Effective Date of January 1, 2006 Notice 60 Day Proposed Information Collection 2005-11-22T05:00:00Z 2005 11 2005-11-21T05:00:00Z   2025-10-08T00:04:53Z 05-23041 0 0 0900006480440bb0
FDA-1998-D-0085-0005 FDA Non-Contraceptive Estrogen Class Labeling FDA-1998-D-0085 FDA Notice NAD-Notice of Availability of Data 2005-11-18T05:00:00Z 2005 11 2005-11-15T05:00:00Z 2006-01-18T04:59:59Z 2008-05-16T21:23:13Z   0 0 0900006480584fcf
FDA-2004-F-0136-0002 FDA Food Additive Petition (FAP No. 4A4758) - Amend the food additive regulations in 172.380 Vitamin D3 (21 CFR 172.380) to permit the use of vitamin D3 in cheese and cheese products at a level above that permitted under 184.1950 Vitamin D (21 CFR 184.1950) FDA-2004-F-0136 Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D3 Notice Notice of Final Rule 2005-11-18T05:00:00Z 2005 11 2005-11-16T05:00:00Z 2005-12-17T04:59:59Z 2025-11-13T02:05:16Z 05-22670 0 0 090000648046fdcc
FDA-2005-N-0039-0001 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Filing Objections and Requests for a Hearing on a Regulation or Order FDA-2005-N-0039 Agency Information Collection Activities; Proposed Collection; Comment Request; Filing Objections and Requests for a Hearing on a Regulation or Order Notice 60 Day Proposed Information Collection 2005-11-18T05:00:00Z 2005 11 2005-11-15T05:00:00Z 2006-01-18T04:59:59Z 2025-10-11T01:58:14Z 05-22753 0 0 090000648043ea8c
FDA-2005-N-0031-0003 FDA Agency Information Collection Activities: Proposed Collection; Comment Request; Importers Entry Notice FDA-2005-N-0031 Agency Information Collection Activities: Submission for Office of Management and Budget Review; Comment Request; Importer's Entry Notice Notice 30 Day Proposed Information Collection 2005-11-18T05:00:00Z 2005 11     2025-10-07T02:14:18Z 05-22671 0 0 090000648043e891
FDA-2005-N-0296-0001 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions (21 CFR Part 10) FDA-2005-N-0296 Agency Information Collection Activities; Proposed Collection; Comment Request; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions Notice 60 Day Proposed Information Collection 2005-11-18T05:00:00Z 2005 11 2005-11-15T05:00:00Z 2006-01-18T04:59:59Z 2025-10-11T01:16:43Z 05-22668 0 0 0900006480446cef
FDA-2005-N-0032-0002 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health Claim FDA-2005-N-0032 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health Claim Notice 30 Day Proposed Information Collection 2005-11-15T05:00:00Z 2005 11 2005-11-14T05:00:00Z   2025-10-07T20:28:59Z 05-22636 0 0 090000648043e8af
FDA-2005-N-0471-0002 FDA Agency Information Collection Activities; Announcement of OMB Approval; Survey on Program Funding FDA-2005-N-0471 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Survey on Program Funding Notice Notice of Approval 2005-11-15T05:00:00Z 2005 11 2005-11-14T05:00:00Z   2025-10-24T01:41:59Z 05-22637 0 0 0900006480450e6c
FDA-2004-N-0319-0002 FDA Amendment to 25.34; Categorical Exclusions Environmental Assessment FDA-2004-N-0319 Environmental Assessment; Categorical Exclusions Notice Notice of Final Rule 2005-11-15T00:00:00Z 2005 11     2025-05-06T16:56:28Z 05-22563 0 0 0900006480473028
FDA-2003-D-0435-0022 FDA Compliance Policy Guide Sec. 110.310 Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 FDA-2003-D-0435 Revised Compliance Policy Guide Regarding Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Availability Notice NAD-Notice of Availability of Data 2005-11-14T05:00:00Z 2005 11 2005-11-14T05:00:00Z 2006-11-15T04:59:59Z 2009-05-13T22:23:05Z   0 0 09000064804a2379
FDA-2004-D-0375-0001 FDA Class II Special Controls Guidance Document: Labeling for Male Condoms Made of Natural Rubber Latex FDA-2004-D-0375 FDA Notice NAD-Notice of Availability of Data 2005-11-14T05:00:00Z 2005 11 2005-11-14T05:00:00Z 2006-02-14T04:59:59Z 2008-11-07T13:05:35Z   0 0 0900006480473751
FDA-2005-P-0374-0001 FDA Classification of the Low Energy Ultrasound Wound Cleaner FDA-2005-P-0374 Medical Devices; General and Plastic Surgery Devices; Classification of the Low Energy Ultrasound Wound Cleaner Notice Notice of Final Rule 2005-11-10T05:00:00Z 2005 11 2005-11-04T05:00:00Z   2025-03-20T14:23:21Z   0 0 090000648044b811
FDA-2003-N-0319-0004 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Study to Measure the Compliance of Prescribers with the Contraindication of the Use of b Triptansb in Migraine Headache Patients with Vascular Disease FDA-2003-N-0319 Agency Information Collection, Activities; Submission for Office of Management and Budget Review; Comment Request; Study to Measure the Compliance of Prescribers With the Contraindication of the Use of Triptans in Migraine Headache Patients With Vascular Disease Notice 30 Day Proposed Information Collection 2005-11-10T05:00:00Z 2005 11 2005-11-02T05:00:00Z 2005-12-03T04:59:59Z 2025-06-17T17:03:30Z 05-21807 0 0 09000064804956b9
FDA-2001-D-0573-0007 FDA Proposed Globally Harmonized Alternative for PMA Procedures FDA-2001-D-0573 FDA Notice NAD-Notice of Availability of Data 2005-11-10T05:00:00Z 2005 11 2005-11-09T05:00:00Z 2006-11-10T04:59:59Z 2008-04-25T02:39:21Z   0 0 090000648050b1d0
FDA-2005-D-0085-0001 FDA Class II Special Controls Guidance Document: Tinnitus Masker Devices FDA-2005-D-0085 FDA Notice NAD-Notice of Availability of Data 2005-11-09T05:00:00Z 2005 11 2005-11-07T05:00:00Z 2006-02-07T04:59:59Z 2008-04-11T23:46:33Z   0 0 090000648043f47e
FDA-2005-N-0298-0001 FDA Ear, Nose, and Throat Devices; Tinnitus Masker; Designation of Special Controls FDA-2005-N-0298 FDA Notice NPR-Notice of Proposed Rule-Making 2005-11-08T05:00:00Z 2005 11 2005-11-07T05:00:00Z 2006-02-07T04:59:59Z 2008-04-11T23:54:03Z   0 0 0900006480446e24
FDA-2004-D-0370-0007 FDA Guidance for Industry: Validation of Analytical Procedures for Type C Medicated Feeds FDA-2004-D-0370 FDA Notice NAD-Notice of Availability of Data 2005-11-08T05:00:00Z 2005 11 2005-11-07T05:00:00Z 2006-11-09T04:59:59Z 2008-04-12T00:35:56Z   0 0 09000064804736e4
FDA-2004-N-0451-0005 FDA Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards FDA-2004-N-0451 Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 013 Notice Notice of Publication 2005-11-08T05:00:00Z 2005 11 2005-11-08T05:00:00Z   2025-04-16T15:43:15Z 05-22267 0 0 090000648047542b
FDA-2005-N-0233-0001 FDA Change of Name; Technical Amendment FDA-2005-N-0233 Change of Name; Technical Amendment Notice N-Notice 2005-11-08T05:00:00Z 2005 11 2005-11-07T05:00:00Z   2025-10-09T22:55:49Z 05-22167 0 0 0900006480442262
FDA-2005-N-0095-0001 FDA Possible Changes to Regulatory Jurisdiction of Certain Food Products Containing Meat and Poultry. Notice of Public Meeting. FDA-2005-N-0095 FDA Notice NM-Notice of Meeting 2005-11-07T05:00:00Z 2005 11 2005-11-04T05:00:00Z   2008-04-11T23:49:59Z   0 0 090000648043f79f
FDA-2005-N-0099-0002 FDA Prescription Drug User Fee Act (PDUFA): Public Meeting FDA-2005-N-0099 FDA Notice NCR-Notice of Correction 2005-11-07T05:00:00Z 2005 11 2005-10-27T04:00:00Z   2008-04-11T23:50:04Z   0 0 090000648043f81b
FDA-2002-E-0283-0004 FDA Patent Term Application for Zometa No. 4,939,130 FDA-2002-E-0283 Determination of Regulatory Review Period for Purposes of Patent Extension; ZOMETA; Correction Notice Correction 2005-11-07T05:00:00Z 2005 11     2025-09-30T18:16:40Z 05-22012 0 0 090000648049eaa1
FDA-2005-G-0193-0001 FDA Guidance for Industry and FDA Staff: Class II Special Controls Guidance Document: Low Energy Ultrasound Wound Cleaner FDA-2005-G-0193 Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Low Energy Ultrasound Wound Cleaner; Availability Notice Notice of Data Availability 2005-11-07T05:00:00Z 2005 11 2005-11-07T05:00:00Z   2025-12-04T01:23:48Z 05–22069 0 0 0900006480440e70
FDA-2005-N-0239-0001 FDA Emergency Shortages Data Collection System FDA-2005-N-0239 Agency Information Collection Activities; Proposed Collection; Comment Request; Emergency Shortages Data Collection System (Formerly the Emergency Medical Device Shortage Program Survey) Notice 60 Day Proposed Information Collection 2005-11-07T05:00:00Z 2005 11 2005-11-04T05:00:00Z 2006-01-04T04:59:59Z 2025-07-15T17:47:47Z   0 0 090000648044409e
FDA-2004-N-0186-0004 FDA Agency Information Collection Activities: Proposed Collection; Comment Request; 2005 Food Safety Survey FDA-2004-N-0186 Agency information Collection Activities; Announcement of Office of Management and Budget Approval; 2005 Food Safety Survey; Correction Notice Correction 2005-11-07T00:00:00Z 2005 11     2025-05-09T00:04:56Z 05-21974 0 0 0900006480470292
FDA-2005-N-0348-0001 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of Participation FDA-2005-N-0348 Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of Participation Notice 60 Day Proposed Information Collection 2005-11-01T05:00:00Z 2005 11 2005-10-31T04:00:00Z 2006-01-04T04:59:59Z 2025-10-11T01:43:23Z 05-21774 0 0 0900006480449e6d
FDA-2005-D-0337-0001 FDA Guidance for Industry: A Notice from the Food and Drug Administration to Growers, Food Manufacturers, Food Warehouse Managers, and Transporters of Food Products on Decontamination of Transport Vehicles; Availability FDA-2005-D-0337 FDA Notice NAD-Notice of Availability of Data 2005-11-01T05:00:00Z 2005 11 2005-11-01T05:00:00Z 2006-11-02T04:59:59Z 2008-04-11T23:47:19Z   0 0 0900006480448edc
FDA-2005-D-0456-0001 FDA Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: CFTR Gene Mutation Detection System FDA-2005-D-0456 FDA Notice NAD-Notice of Availability of Data 2005-10-27T04:00:00Z 2005 10 2005-10-25T04:00:00Z   2008-04-11T23:47:40Z   0 0 0900006480450906
FDA-2005-P-0001-0001 FDA Medical Devices; Immunology and Microbiology Devices; Classification of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Detection System FDA-2005-P-0001 Medical Devices; Immunology and Microbiology Devices; Classification of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutation Detection System Notice Notice of Final Rule 2005-10-27T04:00:00Z 2005 10 2005-10-25T04:00:00Z   2025-03-20T14:27:26Z   0 0 090000648043af8b
FDA-2005-N-0351-0002 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Generic FDA Rapid Response Surveys FDA-2005-N-0351 Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Food and Drug Administration Rapid Response Surveys Notice 60 Day Proposed Information Collection 2005-10-27T04:00:00Z 2005 10 2005-10-24T04:00:00Z 2005-12-28T04:59:59Z 2025-10-24T01:37:11Z 05-21240 0 0 090000648044a08f
FDA-2005-N-0160-0002 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Food Contact Substances Notification System FDA-2005-N-0160 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Food Contact Substances Notification Notice 30 Day Proposed Information Collection 2005-10-25T04:00:00Z 2005 10 2005-10-21T04:00:00Z   2025-10-06T21:55:56Z 05-21155 0 0 09000064804403cb
FDA-2005-N-0288-0002 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices: Humanitarian Use Devices FDA-2005-N-0288 Agency Information Collection Activities; Submission Management and Budget Review; Comment Request; Medical Devices: Humanitarian Use Devices Notice 30 Day Proposed Information Collection 2005-10-25T04:00:00Z 2005 10 2005-10-21T04:00:00Z   2025-10-06T22:14:12Z 05-21158 0 0 0900006480445a35
FDA-2005-N-0299-0001 FDA Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Formal Meetings with Sponsors and Applicants for Prescription Drug User Fee Act FDA-2005-N-0299 Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Formal Meetings with Sponsors and Applicants for Prescription Drug User Fee Act Products Notice 60 Day Proposed Information Collection 2005-10-25T04:00:00Z 2005 10 2005-10-24T04:00:00Z 2005-12-24T04:59:59Z 2025-10-08T22:28:41Z 05-21151 0 0 0900006480446ec0
FDA-2004-D-0045-0005 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 FDA Notice 30 Day Proposed Information Collection 2005-10-25T04:00:00Z 2005 10 2005-10-21T04:00:00Z   2016-08-05T13:58:14Z   0 0 090000648046e856
FDA-2005-N-0161-0002 FDA Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components; and Requirements for Donor Testing, Donor Notification, and Lookback FDA-2005-N-0161 FDA Notice N-Notice 2005-10-25T04:00:00Z 2005 10 2005-10-21T04:00:00Z   2008-04-11T23:50:21Z   0 0 09000064804403fc
FDA-2005-N-0106-0001 FDA Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Formal Dispute Resolution; Appeals Above the Division Level FDA-2005-N-0106 Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Formal Dispute Resolution; Appeals Above the Division Level Notice 60 Day Proposed Information Collection 2005-10-25T04:00:00Z 2005 10 2005-10-24T04:00:00Z   2025-10-08T22:44:15Z 05-21156 0 0 090000648043f948
FDA-2004-N-0186-0003 FDA Agency Information Collection Activities: Proposed Collection; Comment Request; 2005 Food Safety Survey FDA-2004-N-0186 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; 2005 Food Safety Survey Notice Notice of Approval 2005-10-25T00:00:00Z 2005 10     2025-05-08T23:58:48Z 05-21157 0 0 0900006480470290
FDA-2004-D-0366-0006 FDA International Conference on Harmonisation; Draft Guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals FDA-2004-D-0366 FDA Notice NAD-Notice of Availability of Data 2005-10-20T04:00:00Z 2005 10 2005-10-19T04:00:00Z   2008-04-12T00:35:52Z   0 0 09000064804736ab
FDA-2005-D-0014-0001 FDA Guidance for Industry on Recommendations for Implementing a Collection Program for Source Plasma Containing Disease-Associated and Other Immunoglobulin (IgG) Antibodies FDA-2005-D-0014 FDA Notice NAD-Notice of Availability of Data 2005-10-20T04:00:00Z 2005 10 2005-10-19T04:00:00Z 2006-01-19T04:59:59Z 2008-04-11T23:46:17Z   0 0 090000648043e54f
FDA-2004-D-0241-0006 FDA International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs FDA-2004-D-0241 FDA Notice NAD-Notice of Availability of Data 2005-10-20T04:00:00Z 2005 10 2005-10-19T04:00:00Z   2008-04-12T00:35:20Z   0 0 0900006480471999
FDA-2000-P-0152-0002 FDA Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 FDA Notice NPR-Notice of Proposed Rule-Making 2005-10-19T04:00:00Z 2005 10 2005-10-18T04:00:00Z 2020-03-31T03:59:59Z 2020-01-14T02:04:19Z   0 0 09000064804d1295
FDA-2005-N-0295-0001 FDA Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments FDA-2005-N-0295 Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments Notice NM-Notice of Meeting 2005-10-19T04:00:00Z 2005 10 2005-10-17T04:00:00Z 2006-01-18T04:59:59Z 2010-03-19T20:56:27Z   0 0 0900006480446aac
FDA-2003-D-0197-0001 FDA Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format and Related Submissions FDA-2003-D-0197 FDA Notice NAD-Notice of Availability of Data 2005-10-19T04:00:00Z 2005 10 2005-10-18T04:00:00Z   2008-04-12T00:54:53Z   0 0 090000648048b78f
FDA-2005-N-0099-0001 FDA Prescription Drug User Fee Act (PDUFA): Public Meeting FDA-2005-N-0099 FDA Notice NM-Notice of Meeting 2005-10-18T04:00:00Z 2005 10 2005-10-14T04:00:00Z 2005-12-15T04:59:59Z 2008-04-11T23:50:03Z   0 0 090000648043f811
FDA-2005-N-0107-0002 FDA Solicitation of Public Review and Comment on Research Protocol:Gonadotropin-releasing Hormone (GnRH) Agonist Test in Disorders of Puberty. FDA-2005-N-0107 Pediatric Ethics Subcommittee of the Pediatric Advisory Committee; Notice of Meeting Notice Meeting 2005-10-14T04:00:00Z 2005 10 2005-10-06T04:00:00Z   2025-10-09T21:32:48Z 05-20302 0 0 090000648043f96a
FDA-2005-N-0107-0001 FDA Solicitation of Public Review and Comment on Research Protocol:Gonadotropin-releasing Hormone (GnRH) Agonist Test in Disorders of Puberty. FDA-2005-N-0107 Solicitation of Public Review and Comment on Research Protocol: Gonadotropin-releasing Hormone Agonist Test in Disorders of Puberty Notice Request for Comments 2005-10-14T04:00:00Z 2005 10 2005-10-07T04:00:00Z 2005-11-02T04:59:59Z 2025-10-10T09:00:11Z 05-20301 0 0 090000648043f968
FDA-2005-N-0466-0002 FDA Regulations Under the Federal Import Milk Act FDA-2005-N-0466 Agency information Collection Activities; Submission for Office of Management and Budget Review; Regulations Under the Federal Import Milk Act Notice 30 Day Proposed Information Collection 2005-10-14T04:00:00Z 2005 10     2025-10-24T00:52:00Z 05-20148 0 0 0900006480450dc9
FDA-2005-N-0406-0001 FDA Agency Information Collection Activities: Proposed Collection; Comment Request; Investigational New Drug Regulations FDA-2005-N-0406 Agency Information Collection Activities: Proposed Collection; Comment Request; Investigational New Drug Regulations Notice 60 Day Proposed Information Collection 2005-10-12T04:00:00Z 2005 10 2005-10-11T04:00:00Z 2005-12-13T04:59:59Z 2025-07-11T22:24:42Z   0 0 090000648044edc2
FDA-2005-N-0290-0004 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, and Forms FDA 356h and 2567 FDA-2005-N-0290 Agency lnformation Collection Activities; Announcement of Office of Management and Budget Approval; General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, and Forms FDA 356h and 2567 Notice Notice of Approval 2005-10-11T04:00:00Z 2005 10 2005-10-10T04:00:00Z   2025-10-23T22:46:13Z 05-20306 0 0 0900006480445c6a
FDA-2005-N-0229-0006 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for industry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body FDA-2005-N-0229 Agency Information Collection Activities; Announcement of Management and Budget Approval; Guidance for industry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body Notice Notice of Approval 2005-10-11T04:00:00Z 2005 10 2005-10-10T04:00:00Z   2025-10-24T00:29:50Z 05-20308 0 0 0900006480442159
FDA-2004-N-0126-0004 FDA Fast Track Drug Development Programs: Designation, Development, and Application Review FDA-2004-N-0126 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry: Fast Track Drug Development Programs-Designation, Development, and Application Review Notice Notice of Approval 2005-10-11T04:00:00Z 2005 10     2025-06-05T18:56:42Z 05-20305 0 0 090000648046fcbb
FDA-2005-D-0156-0001 FDA Guidance for Industry and FDA Staff: Compliance with Section 301 of the Medical Device User Fee and Modernization Act of 2002, as amended Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices FDA-2005-D-0156 FDA Notice NAD-Notice of Availability of Data 2005-10-11T04:00:00Z 2005 10 2005-10-10T04:00:00Z 2005-10-12T03:59:59Z 2008-04-11T23:46:46Z   0 0 0900006480440268
FDA-2004-N-0450-0007 FDA Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-CounterHuman Use; Proposed Amendment of Monograph for OTC Nasal Decongestant Drug Products FDA-2004-N-0450 Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph for Over-the-Counter Nasal Decongestant Druq Products Notice Notice of Final Rule 2005-10-11T04:00:00Z 2005 10 2005-10-10T04:00:00Z   2025-09-26T17:39:57Z 05-20304 0 0 0900006480475408
FDA-2005-N-0090-0002 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Cosmetic Product Voluntary Reporting Program FDA-2005-N-0090 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Cosmetic Product Voluntary Reporting Program Notice 30 Day Proposed Information Collection 2005-10-11T04:00:00Z 2005 10     2025-10-06T22:21:42Z 05-20307 0 0 090000648043f51a
FDA-2005-D-0458-0001 FDA Guidance for Industry and Food and Drug Administration Staff; Functional Indications for Implantable Cardioverter Defibrillators FDA-2005-D-0458 FDA Notice NAD-Notice of Availability of Data 2005-10-06T04:00:00Z 2005 10 2005-10-05T04:00:00Z 2006-01-05T04:59:59Z 2008-04-11T23:47:43Z   0 0 0900006480450967
FDA-2002-N-0323-0163 FDA Bioterrorism Preparedness; Registration of Food Facilities FDA-2002-N-0323 Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Final Rule Notice NFR-Notice of Final Rule 2005-10-05T04:00:00Z 2005 10 2005-09-30T04:00:00Z   2009-10-27T19:51:30Z   0 0 09000064804a0b54
FDA-2005-D-0088-0001 FDA International Conference on Harmonisation; Draft Guidance on E2B(R) Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports; Availability FDA-2005-D-0088 FDA Notice NAD-Notice of Availability of Data 2005-10-05T04:00:00Z 2005 10 2005-10-03T04:00:00Z 2006-10-04T03:59:59Z 2008-04-11T23:46:35Z   0 0 090000648043f4a5

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;